---
figid: PMC9214054__gr8
figtitle: Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway
  and ameliorate disordered glucose and lipid metabolism
organisms:
- NA
pmcid: PMC9214054
filename: gr8.jpg
figlink: /pmc/articles/PMC9214054/figure/fig8/
number: F8
caption: Graphic illustration of the mechanism of GPS in ameliorating insulin resistance.
  In diabetes, the up-regulated PAQR3 shunts cytosolic p110α to the Golgi apparatus
  while competing with p85α subunit in forming a PI3K complex with p110α, thereby
  negatively regulating insulin signaling. GPS treatment ameliorated high-fat diet
  (HFD) and palmitatic acid (PA)-induced hepatic insulin resistance by promoting PI3K/AKT
  axis activation. Mechanistically, on the one hand, GPS facilitated the interaction
  between DDB2 and PAQR3 to promote DDB2-mediated PAQR3 ubiquitin degradation, on
  the other hand, GPS directly bound to PAQR3 and spatially inhibited the interaction
  between PAQR3 and the PI3K catalytic subunit (P110α) to restore the PI3K/AKT signaling
  pathway.
papertitle: Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway
  and ameliorate disordered glucose and lipid metabolism.
reftext: Haiming Xiao, et al. Acta Pharm Sin B. 2022 Jun;12(6):2887-2904.
year: '2022'
doi: 10.1016/j.apsb.2021.12.023
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Gentiopicroside | Insulin resistance | PAQR3 | PI3K/AKT | DDB2 | Ubiquitylation
  | Glucose metabolism disorder | Lipid metabolism disorder
automl_pathway: 0.9278023
figid_alias: PMC9214054__F8
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9214054__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9214054__gr8.html
  '@type': Dataset
  description: Graphic illustration of the mechanism of GPS in ameliorating insulin
    resistance. In diabetes, the up-regulated PAQR3 shunts cytosolic p110α to the
    Golgi apparatus while competing with p85α subunit in forming a PI3K complex with
    p110α, thereby negatively regulating insulin signaling. GPS treatment ameliorated
    high-fat diet (HFD) and palmitatic acid (PA)-induced hepatic insulin resistance
    by promoting PI3K/AKT axis activation. Mechanistically, on the one hand, GPS facilitated
    the interaction between DDB2 and PAQR3 to promote DDB2-mediated PAQR3 ubiquitin
    degradation, on the other hand, GPS directly bound to PAQR3 and spatially inhibited
    the interaction between PAQR3 and the PI3K catalytic subunit (P110α) to restore
    the PI3K/AKT signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pa
  - Akt
  - 'Off'
  - 'On'
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MICE
  - AKT1
  - AKT2
  - AKT3
  - NBEAL2
  - PAQR3
  - DDB2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
---
